Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzanne I Anjie

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 2, 2025
ReplySuzanne I Anjie, Geert R D'Haens
Endoscopic Ultrasound|February 15, 2021
Surprising stomach cystsSuzanne I Anjie, Berrie Meijer, Liesbeth M Kager
Expert Opinion on Biological Therapy|April 3, 2023
Efficacious dosing regimens for anti-TNF therapies in inflammatory bowel disease: where do we stand?Suzanne I Anjie, Melanie S Hulshoff, Geert D'Haens
Scandinavian Journal of Gastroenterology|November 14, 2023
Anti-drug antibodies against anti-TNF in patients with inflammatory bowel disease: an evaluation of possible strategiesSuzanne I Anjie, Jurij Hanzel, Krisztina B Gecse, et al.
Clinical Case Reports|January 22, 2024
Symptomatic creatine phosphokinase elevation in a Crohn's disease patient caused by upadacitinibAnna Schuitema, Suzanne I Anjie, Agnies M van Eeghen, et al.
Therapeutic Advances in Gastroenterology|February 26, 2024
Subcutaneous vedolizumab interval extension in inflammatory bowel disease patients: a case seriesSuzanne I Anjie, Krisztina B Gecse, Cyriel Y Ponsioen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 16, 2025
Immunogenicity and Efficacy of Subcutaneous Infliximab Monotherapy vs Combination Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-analysisSuzanne I Anjie, Krisztina B Gecse, Chiara M Meloni, et al.
Inflammatory Bowel Diseases|May 7, 2025
Clinical Utility and Accuracy of Point-of-Care Testing for Anti-TNF Drug Monitoring and Loss of ResponseChristoph Teichert, Suzanne I Anjie, Toer W Stevens, et al.
Inflammatory Bowel Diseases|November 10, 2025
Higher Vedolizumab Clearance Associates with Poor Therapeutic Outcomes during Intravenous Vedolizumab Maintenance Therapy in Crohn's DiseaseSuzanne I Anjie, Geert R D'Haens, Filip Baert, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 2, 2025
ReplySuzanne I Anjie, Geert R D'Haens
Endoscopic Ultrasound|February 15, 2021
Surprising stomach cystsSuzanne I Anjie, Berrie Meijer, Liesbeth M Kager
Expert Opinion on Biological Therapy|April 3, 2023
Efficacious dosing regimens for anti-TNF therapies in inflammatory bowel disease: where do we stand?Suzanne I Anjie, Melanie S Hulshoff, Geert D'Haens
Scandinavian Journal of Gastroenterology|November 14, 2023
Anti-drug antibodies against anti-TNF in patients with inflammatory bowel disease: an evaluation of possible strategiesSuzanne I Anjie, Jurij Hanzel, Krisztina B Gecse, et al.
Clinical Case Reports|January 22, 2024
Symptomatic creatine phosphokinase elevation in a Crohn's disease patient caused by upadacitinibAnna Schuitema, Suzanne I Anjie, Agnies M van Eeghen, et al.
Therapeutic Advances in Gastroenterology|February 26, 2024
Subcutaneous vedolizumab interval extension in inflammatory bowel disease patients: a case seriesSuzanne I Anjie, Krisztina B Gecse, Cyriel Y Ponsioen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 16, 2025
Immunogenicity and Efficacy of Subcutaneous Infliximab Monotherapy vs Combination Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-analysisSuzanne I Anjie, Krisztina B Gecse, Chiara M Meloni, et al.
Inflammatory Bowel Diseases|May 7, 2025
Clinical Utility and Accuracy of Point-of-Care Testing for Anti-TNF Drug Monitoring and Loss of ResponseChristoph Teichert, Suzanne I Anjie, Toer W Stevens, et al.
Inflammatory Bowel Diseases|November 10, 2025
Higher Vedolizumab Clearance Associates with Poor Therapeutic Outcomes during Intravenous Vedolizumab Maintenance Therapy in Crohn's DiseaseSuzanne I Anjie, Geert R D'Haens, Filip Baert, et al.
Pageof 1